Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 8

Results: 18

Pembrolizumab: A reliable second‐line treatment option for advanced esophageal cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1233, doi. 10.1111/1759-7714.14395

By:

Zheng, Li;
Zhu, Yabi;
Liu, Yangyang;
Ma, Xu;
Xu, Fang

Publication type:

Article

Assessment of textbook outcome after lobectomy for early‐stage non‐small cell lung cancer in a Korean institution: A retrospective study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1211, doi. 10.1111/1759-7714.14391

By:

Yu, Woo Sik;
Shin, Jaeyong;
Son, Jung A;
Jung, Joonho;
Haam, Seokjin

Publication type:

Article

Establishment and characterization of a novel highly malignant lung cancer cell line ZX2021H derived from a metastatic lymph node lesion.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1199, doi. 10.1111/1759-7714.14385

By:

Zu, Lingling;
Li, Xuebing;
He, Jinling;
Zhou, Ning;
Meng, Fanrong;
Li, Xiaozhou;
Xu, Song;
Zhang, Lei

Publication type:

Article

Could intracranial tumor volume predict prognosis of patients with brain metastases from esophageal carcinoma?

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1193, doi. 10.1111/1759-7714.14384

By:

Xiao, Linlin;
Lin, Qiang;
Hu, Mengzhu;
Wang, Yi;
Hui, Zhouguang;
Wu, Fengpeng;
Wang, Jun

Publication type:

Article

High mRNA expression of POU2F3 in small cell lung cancer cell lines predicts the effect of lurbinectedin.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1184, doi. 10.1111/1759-7714.14382

By:

Matsui, Shinji;
Haruki, Tomohiro;
Oshima, Yuki;
Kidokoro, Yoshiteru;
Sakabe, Tomohiko;
Umekita, Yoshihisa;
Nakamura, Hiroshige

Publication type:

Article

Application of three‐dimensional reconstruction of left upper lung lobes in anatomical segmental resection.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1176, doi. 10.1111/1759-7714.14379

By:

Fan, Kun;
Feng, Jinteng;
Li, Yixing;
Liu, Bohao;
Tao, Runyi;
Wang, Zhiyu;
Zhao, Heng;
Zhang, Yanpeng;
Wang, Jiansheng;
Zhang, Guangjian

Publication type:

Article

Circ_0003340 downregulation mitigates esophageal squamous cell carcinoma progression by targeting miR‐940/PRKAA1 axis.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1164, doi. 10.1111/1759-7714.14377

By:

Guan, Xingzhuo;
Guan, Xiaohui;
Wang, Yuanshi;
Lan, Tingzhu;
Cheng, Tongshuang;
Cui, Yan;
Xu, Hongjun

Publication type:

Article

Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1227, doi. 10.1111/1759-7714.14374

By:

Yukawa, Takuro;
Ishida, Yuta;
Naomoto, Yoshio;
Monobe, Yasumasa;
Fukazawa, Takuya;
Yamatsuji, Tomoki

Publication type:

Article

Downregulation of PD‐L1 and HLA‐I in non‐small cell lung cancer with ALK fusion.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1153, doi. 10.1111/1759-7714.14372

By:

Mu, Di;
Guo, Jingjing;
Yu, Wenwen;
Zhang, Jiali;
Ren, Xiubao;
Han, Ying

Publication type:

Article

Correspondence on "Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non‐small‐cell lung cancer patient".

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1232, doi. 10.1111/1759-7714.14371

By:

Mungmunpuntipantip, Rujittika;
Wiwanitkit, Viroj

Publication type:

Article

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1143, doi. 10.1111/1759-7714.14370

By:

Jia, Bin;
Gong, Ting;
Sun, Bingsheng;
Zhang, Zhenfa;
Zhong, Diansheng;
Wang, Changli

Publication type:

Article

Epidemiologic evaluation of pleurisy diagnosed by surgical pleural biopsy using data from a nationwide administrative database.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1136, doi. 10.1111/1759-7714.14368

By:

Hara, Kanako;
Yamasaki, Kei;
Tahara, Masahiro;
Ikegami, Hiroaki;
Nishida, Chinatsu;
Muramutsu, Keiji;
Fujino, Yoshihisa;
Matsuda, Shinya;
Fushimi, Kiyohide;
Mukae, Hiroshi;
Yatera, Kazuhiro

Publication type:

Article

Pretreatment HDL‐C and ApoA1 are predictive biomarkers of progression‐free survival in patients with EGFR mutated advanced non‐small cell lung cancer treated with TKI.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1126, doi. 10.1111/1759-7714.14367

By:

Ma, Juan;
Bai, Ying;
Liu, Mei;
Jiao, Tong;
Chen, Yang;
Yuan, Bo;
Liu, Boxuan;
Zeng, Lizhong;
Ming, Zongjuan;
Li, Wei;
Sun, Ruiying;
Yang, Xia;
Yang, Shuanying

Publication type:

Article

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1117, doi. 10.1111/1759-7714.14366

By:

Qiao, Zhongshi;
Dai, Chengcheng;
Wang, Zhiqian;
Wang, Zifan;
Wang, Zheng;
Zhang, Tongsong;
Niu, Wenjing;
Ma, Xuezhen

Publication type:

Article

Resected stage I anaplastic lymphoma kinase‐positive lung adenocarcinoma has a negative impact on recurrence‐free survival.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1109, doi. 10.1111/1759-7714.14365

By:

Fujibayashi, Yusuke;
Tane, Shinya;
Kitazume, Mai;
Kuroda, Sanae;
Kimura, Kenji;
Kitamura, Yoshitaka;
Nishio, Wataru

Publication type:

Article

Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1224, doi. 10.1111/1759-7714.14357

By:

Park, Ji Eun;
Yoon, Young‐Ran;
Kim, Chang Ho;
Lee, Jaehee

Publication type:

Article

Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report.

Published in:

Thoracic Cancer, 2022, v. 13, n. 8, p. 1220, doi. 10.1111/1759-7714.14352

By:

Makiguchi, Tomonori;
Fukushima, Takashi;
Tanaka, Hisashi;
Taima, Kageaki;
Takayasu, Shinobu;
Tasaka, Sadatomo

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2022, v. 13, n. 8, p. 1107, doi. 10.1111/1759-7714.14022
Publication type:: Article